TY - JOUR AU - Vishal Prajapati AU - Rahulgiri Goswami AU - Pratik Makvana AU - Jitendra Kumar Badjatya PY - 2014/03/06 Y2 - 2024/03/29 TI - A REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIA JF - International Journal of Drug Regulatory Affairs JA - Int J Drug Reg Affairs VL - 2 IS - 1 SE - Review DO - 10.22270/ijdra.v2i1.7 UR - https://ijdra.com/index.php/journal/article/view/7 AB - Developing a new drug requires great amount of research work in chemistry, manufacturing, controls, preclinical science and clinical trials. Drug reviewers in regulatory agencies around the world bear the responsibility of evaluating whether the research data support the safety, effectiveness and quality control of a new drug product to serve the public health. Every country has its own regulatory authority, which is responsible to enforce the rules and regulations and issue the guidelines to regulate the marketing of the drugs. This article focuses on drug approval process in different countries like USA, Europe and India.  ER -